Federal Health Minister Sussan Ley has confirmed the go-ahead for the Pharmacy Diabetes Screening Services trial set to begin next month.
More than 600 randomly selected community pharmacies around Australia were invited to register interest in the trial, which is a collaboration between the Pharmacy Guild of Australia, the University of Sydney and Deakin University.
The trial selects pharmacies randomly, stratified by metro, regional and rural areas – and invitations to express interest in participation will be sought only from those pharmacies randomly selected.
When registrations close, the project statistician will assess each area and randomly select from those pharmacies that have registered interest. Following the registration-of-interest process, the trial will have a participation quota of 363 pharmacies across Australia.
The objective is to assess the comparative effectiveness and cost-effectiveness of alternative pharmacy-delivered models of opportunistic interventions for diabetes in an asymptomatic, previously undiagnosed population.
The proposed interventions involve the alternative models of screening the general population to facilitate increased risk identification, diagnosis and earlier interventions to prevent the development of diabetes and its complications.
The 6CPA pharmacy trial program was established to trial new and expanded programs that are aimed at improving clinical outcomes for consumers and/or extending the role of pharmacists in the delivery of primary healthcare services through community pharmacy.
“We welcome this progress with the pharmacy trial program,” Pharmacy Guild National President George Tambassis said.
“As Australia’s most accessible health locations, community pharmacies are ideally placed for identifying individuals at high risk of type 2 diabetes and screening them using recognised screening and risk assessment techniques.”